Coronavirus: "cases of cardiac toxicity" after taking hydroxychloroquine

"Cases of cardiac toxicity" have been reported in people with symptoms of Covid-19 who had self-medicated with hydroxychloroquine, promoted by some scientists, don t Pr Raoult, as a possible cure for the virus.

"Cases of cardiac toxicity have been reported [...] following self-medication [...] of hydroxychloroquine in the face of symptoms suggestive of Covid-19, sometimes requiring hospitalization in intensive care," says the Regional Health Agency from Nouvelle-Aquitaine in a press release.

"Faced with this observation, the ARS Nouvelle-Aquitaine warns of the dangers of hydroxychloroquine which must in no case be taken in self-medication", according to the press release.

Its catch must be "monitored"

The taking of this medication must be subject to appropriate medical “supervision” and “prescription” “to avoid the occurrence of serious adverse events but also hospitalizations in intensive care which are currently precious”, continues the ARS.

Derived from the antimalarial chloroquine, hydroxychloroquine known in France as Plaquénil, is used against lupus or rheumatoid arthritis.

Currently tested in several countries in the fight against the virus, these substances can cause many side effects including heart and neurological disorders. And an overdose can be dangerous, even fatal.

In France, trials on hydroxychloroquine are being carried out by the controversial Professor Didier Raoult, who has drawn criticism after having published two studies confirming, according to him, the “effectiveness” of this treatment against the coronavirus. In a second study on 80 patients, published online Friday, the director of the renowned Institut hospitalo-universitaire (IHU) Méditerranée Infection de Marseille, says that 80% of them have experienced a "favorable development".

A decree regulates its availability

However, many scientists point to the limits of these studies, because they were not conducted according to standard scientific protocols.

Newsletter - The essentials of the news

I'm registering

Your email address is collected by Le Parisien to allow you to receive our news and commercial offers. Find out more

In France, a decree regulates the availability of hydroxychloroquine to avoid the risks of rupture while this drug is currently the subject of a craze.

Pending the results of "Discovery", an ongoing European trial on four treatments, including hydroxychloroquine, France has authorized the administration of this molecule against Covid-19 in hospitals only and only in severe cases.

VIDEO. Chloroquine debate: "Patients must benefit from this approach"